Navigating Part 2 Final Rule Updates: Evolving Patient Record Access
On-Demand
Form Header
Form description, sit amet, consectetur et nisl adipiscing elit.
Form description, sit amet, consectetur et nisl adipiscing elit.
The landscape of patient privacy and access in substance use disorder (SUD) treatment will undergo more significant transformation with updates to the Part 2 Final Rule in February 2026.
Join us as we explore upcoming changes to the Final Rule and examine the evolving framework for patient record access. This session is designed for healthcare professionals, compliance officers, and patient advocates seeking to understand the practical implications of these regulatory updates and multiple channels patients can use to obtain health information – ranging from electronic portals and written requests to secure third-party applications.
We’ll break down the major provisions of the Part 2 Final Rule – including enhanced protections, greater alignment with HIPAA, and new consent processes. The webinar will also address challenges and best practices for facilitating record access while maintaining compliance and patient confidentiality.
Don’t miss this vital opportunity to stay ahead of regulatory changes and ensure your organization is equipped to support patient access, privacy, and care continuity in the SUD treatment environment.
Identify and explain the latest requirements of the Part 2 Final Rule.
Develop strategies to effectively balance regulatory compliance with patient empowerment in SUD treatment settings.
Apply real-world solutions and best practices to streamline patient record access within healthcare organizations.
Form description, sit amet, consectetur et nisl adipiscing elit.
Lorem, ipsum dolor sit, amet consectetur adipisicing elit. Accusamus animi nisi sunt fugiat adipisci praesentium rerum explicabo, nostrum, vel porro rem unde, cum ut repudiandae iste, amet ad. Iure, iste!
Totam esse aut perspiciatis autem nam, debitis:
Form description, sit amet, consectetur et nisl adipiscing elit.
Lorem ipsum dolor, sit amet consectetur, adipisicing elit. Reprehenderit, animi.
Top content area. Lorem ipsum dolor sit amet consectetur adipisicing elit. In molestiae esse, sit accusamus ab doloremque tempora maiores officia, odit atque.
Form description, sit amet, consectetur et nisl adipiscing elit.
Bottom content area. Lorem ipsum dolor sit amet, consectetur adipisicing elit. Nostrum inventore magni facilis suscipit odit unde rerum temporibus nesciunt illo tenetur.
Director of Government Affairs and Policy, Verisma
Elizabeth McElhiney, MHA, CHPS, CPHIMS, CDH-L, CRIS, CC, is Director of Government Affairs and Policy at Verisma. She collaborates with clients to implement evidence-based best practices and oversees thought leadership initiatives. Elizabeth has worked in health information and release of information for 15+ years, covering all industry areas from customer service to compliance. She also worked on the team to create the AHIMA ROI microcredential. Elizabeth earned an MHA with a specialization in Health Informatics from Capella University, and a BA in Political Science from Illinois Wesleyan University.
Director of Government Affairs and Policy, Verisma
Elizabeth McElhiney, MHA, CHPS, CPHIMS, CDH-L, CRIS, CC, is Director of Government Affairs and Policy at Verisma. She collaborates with clients to implement evidence-based best practices and oversees thought leadership initiatives. Elizabeth has worked in health information and release of information for 15+ years, covering all industry areas from customer service to compliance. She also worked on the team to create the AHIMA ROI microcredential. Elizabeth earned an MHA with a specialization in Health Informatics from Capella University, and a BA in Political Science from Illinois Wesleyan University.
![]()
In beatae qui delectus modi quod placeat quas aut molestias.
![]()
Veritatis sint eligendi hic neque facilis vero culpa recusandae alias?
![]()
In quia harum accusantium, cumque animi modi a omnis dolorem!
![]()
Optio deleniti quas aut ea dolorem totam nisi vero magni.